How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AL

PAR:Novacyt
Get a brief AI stock analysisSaves ~ 15 minutes of your time

AL

Novacyt SAPAR Novacyt Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XPAR - Euronext Paris

FAIR VALUE

Is ALNOV undervalued compared to its fair value?

The fair value of ALNOV stock is hidden EUR. Relative to the market price of 0.55 EUR Novacyt SA is hidden.

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm devel...[More about valuation]

Novacyt SA Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.042 $B

Price:

0.55 EUR

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.118

FINANCIALS

Novacyt SA financial for reporting period

Income Statement

0.0033 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0084 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0083 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.0033 B 100%
0.0017 B 50%
-0.0084 B -251%
-0.0083 B -250%

Balance Sheet

0.13 B
0.11 B

0.0004 B

Financial Position Analysis

Assets

0.13 B
Current Assets
0.12 B
Total non-current assets
0.012 B

Total current liabilities
0.024 B
Total non-current liabilities
0.0013 B

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0057 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Novacyt SA fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-23 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-95 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-19 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is ALNOV attractive for investment based on fundamental analysis?

ALNOV stock rating is hidden. Novacyt SA is a hidden by Eyestock methodology.

Get ALNOV Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-322

Gross Margin:

43

CFO / Debt ratio:

hidden

Current ratio:

5.171

Debt / Equity ratio:

0.006

ROE:

-23

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

ALNOV.PA analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for ALNOV.PA to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

Novacyt SA competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

Novacyt SA dividends

ALNOV.PA dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About ALNOV.PA stock

About the company Novacyt SA

Market cap $B

0.042

Dividend yield

Shares outstanding

70.6263 B

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. The company is headquartered in Velizy-Villacoublay, Ile-De-France. The company went IPO on 2012-10-12. The firm develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. The firm provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The firm develops secure automated cytology named NovaPrep Processor System. Novacyt SA offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. The firm creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle. Novacyt SA is present in France and internationally through a network of distributors.

ALNOV.PA profile

  • Ticker

    ALNOV.PA

  • Country

    France

  • Exchange

    XPAR - Euronext Paris

  • Report currency

    GBP - British pound

  • IPO date

    12 October 2012

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    276

  • City

    Velizy-Villacoublay

  • Address

    13 Avenue Morane Saulnier

  • Cusip

    F65568101